García-Lerma JG - Search Results

1

Corrigendum to - "Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques" [eBioMedicine 58(2020) 102894].

Massud I, Ruone S, Zlotorzynska M, Haaland R, Mills P, Cong ME, Kelley K, Johnson R, Holder A, Dinh C, Khalil G, Pan Y, Kelley CF, Sanchez T, Heneine W, García-Lerma JG. Massud I, et al. Among authors: garcia lerma jg. EBioMedicine. 2024 Mar;101:105014. doi: 10.1016/j.ebiom.2024.105014. Epub 2024 Feb 13. EBioMedicine. 2024. PMID: 38354533 Free PMC article. No abstract available.

2

Mutation rate and the efficacy of antimicrobial drug treatment.

Gerrish PJ, García-Lerma JG. Gerrish PJ, et al. Lancet Infect Dis. 2003 Jan;3(1):28-32. doi: 10.1016/s1473-3099(03)00485-7. Lancet Infect Dis. 2003. PMID: 12505030 Review.

3

Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT.

García Lerma JG, Yamamoto S, Gómez-Cano M, Soriano V, Green TA, Busch MP, Folks TM, Heneine W. García Lerma JG, et al. J Infect Dis. 1998 May;177(5):1221-9. doi: 10.1086/515272. J Infect Dis. 1998. PMID: 9593007

4

[Quantification of HIV-1 viral load by the measurement of reverse transcriptase activity].

García Lerma JG, Heneine W. García Lerma JG, et al. Med Clin (Barc). 1998 Apr 4;110(12):453-4. Med Clin (Barc). 1998. PMID: 9611714 Spanish. No abstract available.

5

A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC).

García Lerma J, Schinazi RF, Juodawlkis AS, Soriano V, Lin Y, Tatti K, Rimland D, Folks TM, Heneine W. García Lerma J, et al. Antimicrob Agents Chemother. 1999 Feb;43(2):264-70. doi: 10.1128/AAC.43.2.264. Antimicrob Agents Chemother. 1999. PMID: 9925516 Free PMC article.

6

Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma.

Vázquez-Rosales G, García Lerma JG, Yamamoto S, Switzer WM, Havlir D, Folks TM, Richman DD, Heneine W. Vázquez-Rosales G, et al. AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1191-200. doi: 10.1089/088922299310287. AIDS Res Hum Retroviruses. 1999. PMID: 10480632

7

Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity.

García Lerma JG, Soriano V, Mas A, Quiñones-Mateu ME, Arts EJ, Heneine W. García Lerma JG, et al. J Clin Microbiol. 2000 Jan;38(1):402-5. doi: 10.1128/JCM.38.1.402-405.2000. J Clin Microbiol. 2000. PMID: 10618125 Free PMC article.

8

Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1.

García-Lerma JG, Gerrish PJ, Wright AC, Qari SH, Heneine W. García-Lerma JG, et al. J Virol. 2000 Oct;74(20):9339-46. doi: 10.1128/jvi.74.20.9339-9346.2000. J Virol. 2000. PMID: 11000201 Free PMC article.

9

Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors.

Qari SH, Magre S, García-Lerma JG, Hussain AI, Takeuchi Y, Patience C, Weiss RA, Heneine W. Qari SH, et al. J Virol. 2001 Jan;75(2):1048-53. doi: 10.1128/JVI.75.2.1048-1053.2001. J Virol. 2001. PMID: 11134319 Free PMC article.

10

Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.

García-Lerma JG, Heneine W. García-Lerma JG, et al. J Clin Virol. 2001 Jun;21(3):197-212. doi: 10.1016/s1386-6532(00)00163-3. J Clin Virol. 2001. PMID: 11397656 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters